This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Radbruch, L. Articles by Lehmann, K. A Search for Related Content PubMed PubMed Citation Articles by Radbruch, L. Articles by Lehmann, K. A Social Bookmarking                         What's this?

Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine

Rainer Sabatowski

Georg Loick

Pain Clinic, Department of Anaesthesiology, University of Cologne

Carsten Kulbe

Department of Anaesthesiology, Gilead Hospital, Bielefeld

Mario Kasper

Stefan Grond

Klaus A Lehmann

Pain Clinic, Department of Anaesthesiology, University of Cologne, Cologne

Constipation and the use of laxatives were investigated in patients with chronic cancer pain treated with oral morphine and transdermal fentanyl in an open sequential trial. Forty-six patients were treated with slow-release morphine 30–1000 mg/day for 6 days and 39 of these patients were switched to transdermal fentanyl 0.6–9.6 mg/day with a conversion ratio of 100:1. Median fentanyl doses increased from 1.2 to 3.0 mg/day throughout the 30-day transdermal treatment period. Twenty-three patients completed the study. Two patients died from the basic disease while treated with transdermal fentanyl, 12 patients were excluded for various reasons, and not enough data for evaluation were available for two patients. Mean pain intensity decreased slightly after conversion although the number of patients with breakthrough pain or requiring immediate-release morphine as a rescue medication was higher with transdermal fentanyl.

The number of patients with bowel movements did not change after the opioid switch but the number of patients taking laxatives was reduced significantly from 78–87% of the patients per treatment day (morphine) to 22–48% (fentanyl). Lactulose was used mainly and was reduced most drastically, but other laxatives were also used less frequently.

In this study transdermal fentanyl was associated with a significantly lower use of laxatives compared to oral morphine. The difference in the degree of constipation between the two analgesic regimens should be confirmed in a randomized double-blind study that takes into account both constipation and use of laxatives.

Key Words: analgesics • opioid • administration, cutaneous • cathartics • constipation • fentanyl • morphine

Palliative Medicine, Vol. 14, No. 2, 111-119 (2000)
DOI: 10.1191/026921600671594561


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. Devulder, A. Jacobs, U. Richarz, and H. Wiggett Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain Br. J. Anaesth., October 1, 2009; 103(4): 576 - 585. [Abstract] [Full Text] [PDF]

				A. Mazumdar, S. Mishra, S. Bhatnagar, and D. Gupta Intravenous Morphine Can Avoid Distressing Constipation Associated With Oral Morphine: A Retrospective Analysis of Our Experience in 11 Patients in the Palliative Care In-Patient Unit American Journal of Hospice and Palliative Medicine, August 1, 2008; 25(4): 282 - 284. [Abstract] [PDF]

				R. G Twycross, P. McNamara, C. Schuijt, M. A Kamm, and C. Jordan Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study Palliative Medicine, June 1, 2006; 20(4): 419 - 423. [Abstract] [PDF]

				S. Wirz and E. Klaschik Management of constipation in palliative care patients undergoing opioid therapy: Is polyethylene glycol an option? American Journal of Hospice and Palliative Medicine, September 1, 2005; 22(5): 375 - 381. [Abstract] [PDF]

				A. Berger, D. L Hoffman, S. Goodman, T. E Delea, R. Seifeldin, and G. Oster Therapy Switching in Patients Receiving Long-Acting Opioids Ann. Pharmacother., March 1, 2004; 38(3): 389 - 395. [Abstract] [Full Text] [PDF]

				P. McNamara Opioid switching from morphine to transdermal fentanyl for toxicity reduction in palliative care Palliative Medicine, July 1, 2002; 16(5): 425 - 434. [Abstract] [PDF]

				M Barnett Alternative opioids to morphine in palliative care: a review of current practice and evidence Postgrad. Med. J., June 1, 2001; 77(908): 371 - 378. [Full Text]